254 out of 11889 Ayush medicine samples failed test in 3 yrs:

Image
Press Trust of India New Delhi
Last Updated : May 03 2016 | 7:58 PM IST
About 254 out of 11,889 samples of Ayush medicines have failed in quality testing in 24 states in the last three years, Rajya Sabha was informed today.
"States have reported incidents of substandard medicine samples and action taken against them. 11889 samples of AYUSH medicines were tested in 24 states during the last three years from 2013-14 to 2015-16, out of which 254 samples failed in quality testing," Ayush Minister Shripad Yesso Naik said in a written reply.
State licensing authorities initiated appropriate action after the samples failed to comply with the standards and the manufacturing companies issued show cause notices or their licences suspended or cancelled.
Also, the relevant batch of finished goods was recalled from the market and prosecution initiated, he added.
Exclusive regulatory provisions for standards and quality of Ayurvedic, Siddha, Unani and Homoeopathic medicines exist in Drugs and Cosmetics Act, 1940 and Rules thereunder.
"As of now there is no proposal in the Ministry to introduce new legislation for grading and standardisation of Ayush products," he said.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: May 03 2016 | 7:58 PM IST

Next Story